Fine Organics files FY2025-26 annual report; AGM set for Aug 18

Ebitda Margin CompressionResults View source PDF Explain this filing

FINEORG · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.7%Reaction day

₹4834.50

prior close

₹4839.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.3%+0.6% vs market

Specialty Chemicals peers, median of 95sector-1.2%+0.5% vs sector

On the reaction day the stock moved 0.6 pts more than Nifty Microcap 250 and 0.5 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.6

10m

-1.2

15m

-0.9

30m

-1.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.7-1.3+0.6-1.2+0.5

Next day

-0.7-0.8+0.1-0.6-0.2

+1.5-1.4+2.9-2.0+3.5

-0.4-0.3-0.1-1.3+0.9

+1.6+1.0+0.6-0.2+1.9

+1.6+1.5+0.1+0.0+1.6

+2.7+3.1-0.4+1.1+1.6

15d

+5.7+4.1+1.6+0.1+5.6

+9.4+4.8+4.7+2.8+6.6

+6.1+3.1+3.0+1.3+4.8

+5.3-3.6+8.9-6.6+11.9

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 95Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Fine Organics submitted its FY2025-26 annual report with AGM scheduled for August 18, 2026 via video conferencing. Revenue rose about 3.2 percent to Rs 2,276 Crore, but EBITDA fell to Rs 411 Crore (margin compressed to 18.10 percent from 21.8 percent) and PAT declined to Rs 346 Crore from Rs 390 Crore. The company remained debt-free with net cash position, and continued global capacity expansion including a US facility and a Rs 750 Crore SEZ project in India.

Likely market impact

Revenue stable but profitability under pressure with EBITDA and PAT declining; debt-free balance sheet supports ongoing expansion plans.